By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

Research backs this up: Young men who consumed more protein while losing weight and on an intense exercise regiment gained ...

GLP-1 medications like Semaglutide (found in Ozempic and Wegovy) and Tirzepatide (found in Mounjaro) mimic the body’s natural ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re starting a weight loss journey, you might have ...

On Christmas Day, billionaire Elon Musk shocked his followers by sharing a revealing post about his weight-loss journey.

The present meta-analysis indicated that GLP-1RA could significantly reduce the severity of OSA, and also lead to weight loss ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...